Childhood cancers: open trials in Singapore

• NCT05384626

  A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)

  Trial Treatment · Phase 1/2 · Nuvalent Inc.

  National Cancer Centre Singapore, Singapore · National University Hospital, Singapore

  Registry updated 2026-11-06

• NCT04924075

  Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)

  Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC

  National Cancer Centre Singapore (Site 1700), Singapore

  Registry updated 2026-11-03

• NCT07211958

  Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation

  Trial Treatment · Phase 3 · Syndax Pharmaceuticals

  Singapore

  Registry updated 2026-10-21

• NCT04585750

  The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

  Trial Treatment · Phase 1/2 · PMV Pharmaceuticals, Inc

  National University Hospital, Kent Ridge · National Cancer Center of Singapore, Singapore

  Registry updated 2026-10-02

• NCT04094610

  A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National University Hospital, Singapore · KK Women's and Children's Hospital, Singapore

  Registry updated 2026-09-25

• NCT05118789

  A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)

  Trial Treatment · Phase 1/2 · Nuvalent Inc.

  National University Hospital Singapore, Singapore · National Cancer Centre Singapore, Singapore

  Registry updated 2026-09-24

• NCT07247123

  Developing and Testing the Effectiveness of a Skin Cancer Self-Detection Educational Program

  Trial Treatment · National University Hospital, Singapore

  National University Hospital, Singapore

  Registry updated 2026-09-24

• NCT04877522

  Asciminib Roll-over Study

  Trial Treatment · Phase 4 · Novartis Pharmaceuticals

  Singapore

  Registry updated 2026-07-06

• NCT03093116

  A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

  Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.

  National University Hospital, Singapore · National Cancer Center Singapore, Singapore

  Registry updated 2026-05-27

• NCT02806388

  Individualized Molecular Profiling for Allocation to Clinical Trials (IMPACT) Project

  Research · National Cancer Centre, Singapore

  National Cancer Centre Singapore, Singapore

  Registry updated 2026-05-13

• NCT05580562

  ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)

  Trial Treatment · Phase 3 · Jazz Pharmaceuticals

  National Neuroscience Institute, Singapore · KK Women's and Children's Hospital, Singapore · National Cancer Centre, Singapore

  Registry updated 2026-04-16

• NCT07319676

  Antigen Targeted T Cell Therapy for Relapsed/Refractory B Cell Lymphomas

  Trial Treatment · Phase 1/2 · National University Hospital, Singapore

  National University Hospital, Singapore

  Registry updated 2026-04-09

• NCT04988555

  A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

  Trial Treatment · Phase 1/2 · Sumitomo Pharma America, Inc.

  National University Cancer Institute, Singapore

  Registry updated 2026-03-24

• NCT05305131

  Randomised Trial of Induction Gemcitabine and Cisplatin Versus Gemcitabine, Cisplatin, Pembrolizumab and Bevacizumab (GPPB) in Nasopharyngeal Cancer

  Trial Treatment · Phase 2 · National University Hospital, Singapore

  National University Hospital, Singapore

  Registry updated 2025-09-23

• NCT04775485

  A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors

  Trial Treatment · Phase 2 · Day One Biopharmaceuticals, Inc.

  KK Women's and Children's Hospital, Singapore

  Registry updated 2025-04-10

• NCT06676761

  Outcomes of a Novel Technique Minimal Scar Mastectomy

  Research · KK Women's and Children's Hospital

  KK Women's and Children's Hospital, Singapore

  Registry updated 2024-11-06

• NCT06336395

  Ma-Spore ALL 2020 Study

  Trial Treatment · Phase 2 · National University Hospital, Singapore

  KK Women's and Children's Hospital, Singapore

  Registry updated 2024-03-28

• NCT05648019

  CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility Protocol

  Trial Treatment · Phase 2 · KK Women's and Children's Hospital

  KK Women's and Children's Hospital, Singapore · Singapore General Hospital, Singapore

  Registry updated 2023-03-09

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error